Stock Events

Stock Events

Scilex Company 

$5.42
47
+$0.13+2.56% 20:00 Today
-$0.00-0.09%20:22After hours

Statistics

Day High
5.72
Day Low
5.31
52W High
21.34
52W Low
2.62
Volume
40,411
Avg. Volume
115,911
Mkt Cap
38.09M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

2DecExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-22.17
-14.81
-7.44
-0.08
Expected EPS
-0.075589
Actual EPS
N/A

Financials

-1,330.4%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
30.25MRevenue
-402.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SCLX. It's not an investment recommendation.
NVIDIA
7
NVDA
Amazon
6
AMZN
Apple
5
AAPL
Microsoft
5
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing directly with Scilex in the pain management pharmaceutical market.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical segment Janssen, competes in developing treatments for pain, directly overlapping with Scilex's market.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a large pharmaceutical company with a broad portfolio that includes pain management solutions, competing with Scilex's products.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie, with its range of pain management drugs, competes in the same therapeutic areas as Scilex, particularly in chronic pain.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. competes with Scilex through its development and marketing of pharmaceuticals for various conditions, including pain management.
AMGEN
AMGN
Mkt Cap233.78B
Amgen, with its focus on biopharmaceuticals, has products that compete in the pain management space, overlapping with Scilex's interests.
Novartis
NVS
Mkt Cap292.35B
Novartis AG, through its extensive portfolio of medicines, competes in various therapeutic areas including pain management, directly challenging Scilex.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb offers a range of prescription medicines across several therapeutic areas, including pain, competing with Scilex's product offerings.

About

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Show more...
CEO
Henry H. Ji
Employees
34
Country
United States
ISIN
US80880W2052
WKN
000A412WV

Listings

XNAS
US
SCLX
XNAS
US
SCLXW
BOATS
BOATS
SCLX.BOATS
F
DE
D8B0.F

0 Comments

Share your thoughts

FAQ

What is Scilex Company stock price today?▼
The current price of SCLX is $5.42 USD — it has increased by +2.56% in the past 24 hours. Watch Scilex Company stock price performance more closely on the chart.
What is Scilex Company stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Scilex Company stocks are traded under the ticker SCLX.
Is Scilex Company stock price growing?▼
SCLX stock has fallen by -0.28% compared to the previous week, the month change is a -16.31% fall, over the last year Scilex Company has showed a -73.43% decrease.
What is Scilex Company market cap?▼
Today Scilex Company has the market capitalization of 38.09M
When is the next Scilex Company earnings date?▼
Scilex Company is going to release the next earnings report on December 02, 2026.
What is Scilex Company revenue for the last year?▼
Scilex Company revenue for the last year amounts to 30.25M USD.
What is Scilex Company net income for the last year?▼
SCLX net income for the last year is -402.49M USD.
How many employees does Scilex Company have?▼
As of September 04, 2026, the company has 34 employees.
In which sector is Scilex Company located?▼
Scilex Company operates in the Health & Wellness sector.
When did Scilex Company complete a stock split?▼
The last stock split for Scilex Company was on April 15, 2025 with a ratio of 1:35.
Where is Scilex Company headquartered?▼
Scilex Company is headquartered in PALO ALTO, United States.